Longeveron Inc. (LGVN) Form 8-K Material Events
Longeveron Inc. (LGVN) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: LGVN
CIK: 1721484
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
CBIZ CPAs P.C.
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerMichael Brooder
Audit LocationHartford, Connecticut, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-14 | 2026-10-07 | CURRENT REPORT | 0001213900-26-109411 | View SEC Doc Filr Page |
| 4 | 2026-10-05 | 2026-10-01 | PRIMARY DOCUMENT | 0001214659-26-012570 | View SEC Doc Filr Page |
| 4 | 2026-10-05 | 2026-10-01 | PRIMARY DOCUMENT | 0001214659-26-012569 | View SEC Doc Filr Page |
| 4 | 2026-10-05 | 2026-10-01 | PRIMARY DOCUMENT | 0001214659-26-012568 | View SEC Doc Filr Page |
| 4 | 2026-10-05 | 2026-10-01 | PRIMARY DOCUMENT | 0001214659-26-012567 | View SEC Doc Filr Page |
| 4 | 2026-10-05 | 2026-10-01 | PRIMARY DOCUMENT | 0001214659-26-012566 | View SEC Doc Filr Page |
| 8-K | 2026-09-23 | 2026-09-16 | CURRENT REPORT | 0001213900-26-102611 | View SEC Doc Filr Page |
| 8-K | 2026-09-14 | 2026-09-11 | CURRENT REPORT | 0001213900-26-099712 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-09-10 | — | SCHEDULE 13G Filing | 0000935836-26-000483 | View SEC Doc Filr Page |
| 4 | 2026-08-25 | 2026-08-17 | PRIMARY DOCUMENT | 0001214659-26-010852 | View SEC Doc Filr Page |
| 3 | 2026-08-25 | 2026-08-17 | PRIMARY DOCUMENT | 0001214659-26-010851 | View SEC Doc Filr Page |
| 8-K | 2026-08-24 | 2026-08-20 | CURRENT REPORT | 0001213900-26-093028 | View SEC Doc Filr Page |
| 4 | 2026-08-21 | 2026-08-19 | PRIMARY DOCUMENT | 0001214659-26-010743 | View SEC Doc Filr Page |
| 4 | 2026-08-21 | 2026-08-19 | PRIMARY DOCUMENT | 0001214659-26-010742 | View SEC Doc Filr Page |
| 4 | 2026-08-21 | 2026-08-19 | PRIMARY DOCUMENT | 0001214659-26-010741 | View SEC Doc Filr Page |
| 4 | 2026-08-21 | 2026-08-19 | PRIMARY DOCUMENT | 0001214659-26-010740 | View SEC Doc Filr Page |
| 4 | 2026-08-21 | 2026-08-19 | PRIMARY DOCUMENT | 0001214659-26-010739 | View SEC Doc Filr Page |
| 4 | 2026-08-21 | 2026-08-19 | PRIMARY DOCUMENT | 0001214659-26-010736 | View SEC Doc Filr Page |
| 4 | 2026-08-21 | 2026-08-19 | PRIMARY DOCUMENT | 0001214659-26-010738 | View SEC Doc Filr Page |
| 4 | 2026-08-21 | 2026-08-19 | PRIMARY DOCUMENT | 0001214659-26-010735 | View SEC Doc Filr Page |
| 4 | 2026-08-21 | 2026-08-19 | PRIMARY DOCUMENT | 0001214659-26-010737 | View SEC Doc Filr Page |
| 4 | 2026-08-21 | 2026-08-19 | PRIMARY DOCUMENT | 0001214659-26-010734 | View SEC Doc Filr Page |
| 4 | 2026-08-21 | 2026-08-19 | PRIMARY DOCUMENT | 0001214659-26-010733 | View SEC Doc Filr Page |
| 8-K | 2026-08-19 | 2026-08-17 | CURRENT REPORT | 0001213900-26-091677 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0001213900-26-088831 | View SEC Doc Filr Page |